| Line Item | 2025-01-03 | Y/Y |
|---|---|---|
| Revenue | $16.66B | +7.9% |
| Cost of Revenue | $13.86B | +5.1% |
| R&D Expense | $150.0M | +17.2% |
| SG&A Expense | $983.0M | +4.4% |
| Operating Income | $1.83B | +194.2% |
| Pre-tax Income | $1.64B | +306.7% |
| Income Tax | $388.0M | +99.0% |
| Net Income | $1.25B | +530.2% |
| EPS (Basic) | $9.36 |
| Line Item | 2025-01-03 | Y/Y |
|---|---|---|
| Cash & Equivalents | $943.0M | +21.4% |
| Accounts Receivable | $2.65B | +8.9% |
| Inventory | $315.0M | +1.6% |
| Current Assets | $4.43B | +10.6% |
| Total Assets | $13.10B | +3.2% |
| Current Liabilities | $3.65B | +22.2% |
| Long-term Debt | $4.05B | -13.1% |
| Line Item | 2025-01-03 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.39B | +19.5% |
| Investing Cash Flow | -$142.0M | +32.7% |
| Financing Cash Flow | -$1.08B | -51.6% |
| +545.5% |
| EPS (Diluted) | $9.22 | +540.3% |
| Total Liabilities |
| $8.64B |
| +2.5% |
| Stockholders' Equity | $4.41B | +5.0% |